DICOPAC KIT
LOE ApproachingNDAN/AN/A
Approved
Jun 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 43m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DICOPAC KIT is a diagnostic imaging kit sponsored by GE HealthCare, approved in 1974. The specific mechanism of action and therapeutic indication are not publicly documented in available sources. This legacy product represents a foundational diagnostic tool in GE's portfolio.
LOE Approaching
Product approaching loss of exclusivity with low competitive pressure (30/100), indicating a mature, stable franchise with likely smaller team deployment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DICOPAC KIT offers limited career growth opportunity given zero linked job openings and LOE-approaching status. Career value lies in legacy product stewardship, regulatory maintenance, and operational efficiency rather than strategic growth initiatives.
Product Manager (Legacy)Regulatory Affairs Specialist
Worked on DICOPAC KIT at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.